Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
InMed Pharmaceuticals Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Jun 2026 | $71.00M | $71.00M - $71.00M | -$42.60M | $0.00 | 1 |
| Jun 2025 | $6.77M | $6.77M - $6.77M | -$4.06M | -$100.00 | 1 |
| Jun 2024 | $5.42M | $5.42M - $5.42M | -$3.25M | -$321.40 | 1 |
| Jun 2023 | $4.13M | $4.13M - $4.13M | -$2.48M | -$318.35 | 1 |
| Jun 2022 | $1.77M | $1.77M - $1.77M | -$1.06M | -$488.10 | 1 |